Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

IMVT

Immunovant (IMVT)

Immunovant Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:IMVT
일자시간출처헤드라인심볼기업
2024/03/1220:30GlobeNewswire Inc.Immunovant Awarded U.S. Patent for IMVT-1402NASDAQ:IMVTImmunovant Inc
2024/02/2406:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/02/2406:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/02/2406:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/02/1422:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMVTImmunovant Inc
2024/02/1221:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMVTImmunovant Inc
2024/02/1221:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
2024/01/3006:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/01/2006:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/01/1621:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/01/1306:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/01/1006:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/01/1006:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2024/01/0922:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
2024/01/0322:00GlobeNewswire Inc.Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMVTImmunovant Inc
2023/12/2107:40Dow Jones NewsImmunovant Gets Positive Data From Graves' Disease Treatment TrialNASDAQ:IMVTImmunovant Inc
2023/12/2106:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
2023/12/2106:30GlobeNewswire Inc.Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ DiseaseNASDAQ:IMVTImmunovant Inc
2023/12/2106:30GlobeNewswire Inc.Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ DiseaseNASDAQ:IMVTImmunovant Inc
2023/11/2821:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
2023/11/2821:00GlobeNewswire Inc.Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class PotentialNASDAQ:IMVTImmunovant Inc
2023/11/2821:00GlobeNewswire Inc.Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class PotentialNASDAQ:IMVTImmunovant Inc
2023/11/2504:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2023/11/2504:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2023/11/2504:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2023/11/2504:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
2023/11/1322:00GlobeNewswire Inc.Immunovant to Present at Upcoming Investor ConferencesNASDAQ:IMVTImmunovant Inc
2023/11/0922:49Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:IMVTImmunovant Inc
2023/11/0921:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMVTImmunovant Inc
2023/11/0921:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
 검색 관련기사 보기:NASDAQ:IMVT